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1. Introduction 
For centuries, lactic acid bacteria (LAB) have been used for the preservation of food for 
human consumption. LAB are a large group of fermentative, anaerobe facultative, 
aerotolerant microorganisms which are usually present in the gut of humans and other 
animals, raw vegetables, meat and meat products, and cereals (Carr et al., 2002). In animals, 
their numbers may vary with the species, the age of the host, or the location within the gut 
(De Vries et al., 2006). In the food industry, lactic acid bacterial strains are widely employed 
either as starter cultures or as non-starter lactic acid bacteria. Furthermore, owing to their 
probiotic properties, several LAB strains are used as adjunctive cultures in foods and feed 
(Sanders, 2000; Leroy & de Vuyst, 2004). 
The term “probiotic” originated from the Greek word “probios” meaning “for life” (as 
opposed to “antibiotic,” which means “against life”) (Longdet et al., 2011). Probiotics are 
microbial food supplements which, when administered in adequate amounts, confer health 
benefits to consumers by maintaining or improving their intestinal microbial flora (Salminen 
et al., 1998; Reid et al., 2003). The US Food and Drug Administration uses other terms for 
live microbes for regulatory purposes (Sanders, 2008); live microbes used in animal feeds are 
called “direct-fed microbials” (FDA, 1995), and, when intended for use as human drugs, 
they are classified as “live biotherapeutics” (Vaillancourt, 2006). Probiotics are mainly 
members of the genera Lactobacillus and Bifidobacterium and are normal residents of the 
complex ecosystem of the gastrointestinal tract (GIT) of humans.  
The research of novel probiotic strains is important in order to satisfy the increasing request 
of the market and to obtain functional products in which the probiotic cultures are more 
active and with better probiotic characteristics than those already present on the market 
(Verdenelli, et al., 2009). According to a recent market research report ‘Probiotics Market 
(2009-2014)’, the global probiotics market generated US $15.9 billion in 2008 and is expected 
to be worth US $ 32.6 billion by 2014 with a compound annual growth rate of 12.6 percent 
from 2009 to 2014 (FB 1046, 2009). 
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Several aspects, including general, functional and technological characteristics, have to be 
taken into consideration while selecting probiotic strains (Sanders & Huis in’t Veld 1999; 
Šušković et al., 2001). This chapter includes selection criteria of bacteria as probiotics, 
technological usage of probiotics, new approaches for enhancing the performance of 
probiotics, and health effects of probiotic bacteria.  
2. Selection of probiotic bacteria  
Probiotics are living, health-promoting microorganisms that are incorporated into various 
kinds of foods.  Although there has been a growing interest in using LAB isolated both from 
naturally fermented products and humans for health benefits (Lim & Im, 2009), the strains 
should preferably be of human origin and possess a Generally-Recognized-As-Safe status 
(Rönkä et al., 2003).  
In order to exhibit their beneficial effects, probiotic bacteria need to survive during the food-
manufacturing process and in human ecosystem conditions; therefore it is important to 
investigate bacterial behavior under conditions which mimic the GIT (Zago et al., 2011; Lo 
Curto et al., 2011). Stresses to microorganisms begin in the mouth, with the lysozyme-
containing saliva; continue in the stomach, which has a pH between 1.5 and 3.0; and go on 
to the upper intestine, which contains bile (Corzo & Gilliland, 1999). Acid and bile 
tolerances are two fundamental properties that indicate the ability of a probiotic 
microorganism to survive the passage through the GIT, resisting the acidic conditions in the 
stomach and the bile acids at the beginning of the small intestine (Prasad et al., 1998; Park et 
al., 2002). To evaluate the probiotic survival in the GIT, several in vitro static models of 
digestion have been developed (Kitazawa et al., 1991; Charteris et al., 1998). One of them is 
the gastric–small intestinal system TIM-1 (Minekus et al., 1995), which consists of four serial 
compartments simulating the stomach and the three segments of the small intestine: the 
duodenum, jejunum, and ileum. Another one, the TIM-2 model, is a more sophisticated in 
vitro model of fermentation in the proximal large intestine. It consists of a series of linked 
glass vessels containing flexible walls which allow simulation of peristalsis (De Preter et al., 
2011). The simulator of the human intestinal microbial ecosystem (SHIME) was developed 
to simulate the entire human gastrointestinal system (Molly et al., 1993). SHIME consists of a 
series of five temperature- and pH-controlled vessels that simulate the stomach; small 
intestine; and ascending, transverse and descending colon, respectively. The SHIME harbors 
a microbial community resembling that from the human colon both in fermentation activity 
and in composition (De Preter et al., 2011).  Yet another model of the digestive system has 
been developed by such as TNO to mimic human physiological conditions in the stomach 
and small intestine (Blanquet et al., 2001). The major limitations of those systems is that 
digestion products are not removed during the incubation, and they may have a potential 
inhibitory effect on enzyme activities and on probiotic survival (Pitino et al., 2010). 
Furthermore, such systems ignore key GIT physical processes, including the temporal 
nature of gastric and duodenal processing, structure of food, pattern of mixing, particle size 
reduction and shear, which all affect the digestion rate (Shah 2000; Sumeri et al., 2008). 
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Effects of probiotics are strain specific. Strain identity is important in order to link a strain 
with a specific health effect, as well as to enable accurate surveillance and epidemiological 
studies (Ganguly et al., 2011). It is very important to be able to identify specifically and 
unambiguously the particular probiotic LAB strains from clinical fecal and intestinal biopsy 
specimens and from food samples (Tilsala-Timisjärvi & Tapanialtossava, 1998). 
Identification of bacterial species and strains from commercialized probiotics has been 
conducted mostly using molecular methods (Holzapfel et al., 2001; Schillinger et al., 2003; 
Huys et al., 2006; Sheu et al., 2009).  
Verdenelli et al. (2009) investigated the probiotic potential of 11 Lactobacillus strains isolated 
from the faeces of elderly Italians. For this purpose, the researchers identified the 
Lactobacillus strains and examined them for resistance to gastric acidity and bile toxicity, 
adhesion to HT-29 cells, antimicrobial activities, antibiotic susceptibility and plasmid profile. 
They also examined the survival of the strains as they moved through the human intestine 
in a 3-month human feeding trial. According to the results, L. rhamnosus IMC 501 and L. 
paracasei IMC 502 present favourable strain-specific properties for their utilisation as 
probiotics in functional foods. Both in vitro and in vivo studies confirm the high adhesion 
ability of L. rhamnosus IMC 501 and L. paracasei IMC 502, used in combination, indicating 
that the two bacterial strains could be used as health-promoting bacteria. 
Başyiğit Kılıç & Karahan (2010) isolated one hundred seven strains of human originated 
LAB identified by 16S rRNA analysis and examined them for resistance to acidic pH, bile 
salts and antibiotic susceptibility. They found that L. plantarum (AA1–2, AA17–73, AC18–88, 
AK4–11, and AK7–28), L. fermentum (AB5–18, BB16–75, and AK4–180), Enterococcus faecium 
(AB20–98 and BK11–50) and E. durans (AK4–14 and BK9–40) are potentially good probiotic 
candidates for use as health-promoting bacteria. In another study, the L. plantarum strains 
were examined for resistance to gastric acidity in simulated gastric juice at pH 2.0, 2.5, 3.0 
and 3.5; 0.4% phenol; production of H2O2; adhesion to Caco-2 cell line; and antimicrobial 
activities. The researchers determined that the artificial gastric juice, even at pH 2.0, did not 
significantly change the viability of the cultures, and all L. plantarum strains showed good 
resistance to 0.4% phenol. They also reported antimicrobial activity and good adhesion of L. 
plantarum strains to Caco-2 cells. The researchers concluded that all of the strains showed 
probiotic properties, but L. plantarum AB6-25, AB7-35, AA13-59, AB16-65, BC18-81 and AK4-
11 were the best potential probiotic strains for human use, given their ability to survive in 
gastric conditions, strong resistance to phenol, and the ability to adhere to the Caco-2 cell 
line (Başyiğit Kılıç et al., 2011a). 
Lo Curto et al. (2011) investigated the survival of three commercial probiotic strains (L. casei 
subsp. shirota, L. casei subsp. immunitas, L. acidophilus subsp. johnsonii) in the human upper 
GIT. They used a dynamic gastric model (DGM) of digestion followed by incubation under 
duodenal conditions. The DGM is a computer-controlled gastric model which incorporates 
the chemical, biochemical, physical environment and processes of the human stomach; the 
model is based on kinetic data derived from the Echo planar-MRI and data on the rates of GI 
digestion obtained from human studies (Marciani et al., 2001; 2003; 2005; 2006). The 
researchers used water and milk as food matrices, and survival was evaluated in both 
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logarithmic and stationary phases. The researchers found that the % of recovery in the 
logarithmic phase ranged from 1.0% to 43.8% in water for all tested strains, and from 80.5% 
to 197% in milk. They observed higher survival rates in the stationary phase for all strains. L. 
acidophilus subsp. johnsonii showed the highest survival rate in both water (93.9%) and milk 
(202.4%).  
The safety of probiotic bacteria must be carefully assessed, with particular attention to 
transferable antibiotic resistance (Mathur & Singh, 2005). In the last decade, increasing 
concern has arisen about the safe use of LAB cultures for food and feed applications, in light 
of the latest knowledge about their possible role as an antibiotic-resistant gene reservoir. 
Particular concern is due to evidence of widespread occurrence in this bacterial group of 
conjugative plasmids and transposons (Clementi & Aquilanti, 2011). It is known that 
lactobacilli have a high natural resistance to bacitracin, cefoxitin, ciprofloxacin, fusidic acid, 
kanamycin, gentamicin, metronidazole, nitrofurantoin, norfloxacin, streptomycin, 
sulphadiazine, teicoplanin, trimethoprim/sulphamethoxazole, and vancomycin (Danielsen 
& Wind, 2003). 
One of the primary benefits associated with probiotic bacterial cultures is that they can 
exclude pathogenic bacteria from the small and large intestine (Kos et al., 2008). Another 
benefit is that in food products, antimicrobial activity of probiotic bacteria may contribute to 
an improvement in the quality of fermented foods.  This may result from control of spoilage 
and pathogenic bacteria, extension of shelf life, and improvement of sensory quality (Wei et 
al., 2006; Siripatrawan & Harte, 2007). Kos et al. (2008) used overnight cultures and cell-free 
supernatants of the three probiotic strains L. acidophilus M92, L. plantarum L4, and E. faecium 
L3 for determining the antagonistic effect against Listeria monocytogenes, Salmonella 
typhimurium, Yersinia enterocolitica, and Acinetobacter calcoaceticus. The researchers 
determined that probiotic strains L. acidophilus M92, L. plantarum L4, and E. faecium L3 
demonstrated anti-Salmonella activity. L. acidophilus M92 was also shown to have antilisterial 
activity, as demonstrated by in vitro competition test.  
Production of antimicrobial compounds, which may take part in the inhibition of intestinal 
pathogens, is another criterion for classifying a potentially probiotic bacteria (Hutt et al., 
2006). The inhibition of pathogenic microorganisms by selected probiotic strains may occur 
via a) production of antibiotic-like substances, b) bacteriocins and bacteriocin-like inhibitory 
substances such as acidophilin and reuterin, c) lowering of pH by producing organic acids 
such as acetic, lactic and phenyllactic acid, d) production of hydrogen peroxide and short 
chain fatty acids, e) decreasing the redox potential, and f) consumption of available 
nutrients (Holzapfel  et al., 1995; Ouwehand, 1998; Tharmaraj & Shah, 2009). 
The ability of LAB to adhere to epithelial cells and mucosal surfaces is thought to be an 
important property of many bacterial strains used as probiotics (FAO/WHO, 2001). Cell 
adhesion is a complex process involving contact between the bacterial cell membrane and 
interacting surfaces. Difficulties experienced in studying bacterial adhesion in vivo, 
especially in humans, have stimulated interest in the development of in vitro models for 
preliminary screening of potentially adherent strains (Duary et al., 2011). Attachment and 
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colonization of the gut epithelium prolongs the time for microorganisms to influence the 
immune system and microbiota of the host (Forestier et al., 2001). HT-29 and Caco 2 cells, 
the two colonic adenocarcinomas, are derived from human intestinal epithelium.  Because 
they have structural and functional features of normal human enterocytes, they have been 
extensively used as in vitro models in the study of human enterocytic function (Moussavi & 
Adams, 2009). 
The ability of probiotic bacteria to adhere to Caco-2 cells can be determined by plate 
counting or real time PCR (Matijasic et al., 2003; Candela et al., 2005). Nawaz et al. (2011) 
used both of these methods and did not find a statistically significant difference. Gaudana et 
al. (2010) investigated the ability of four different isolates (L. plantarum CS23, L. rhamnosus 
CS25, L. delbrueckii M and L. fermentum ASt1) and two standard strains (L. plantarum ATCC 
8014 and L. rhamnosus GG) to stimulate three types of cells (Caco-2 cells, human peripheral 
blood mononuclear cells [PBMC] and THP-1 cells). The researchers reported that child faecal 
isolate CS23 showed high binding ability, high tolerance to acidic pH and bile salts, and 
significant immunomodulation; therefore they concluded that CS23 can be a good potential 
probiotic candidate. Duary et al. (2011) determined the colonization potentials of five 
human faecal L. plantarum isolates to the Caco-2 cells.  Based on direct adhesion to epithelial 
cells, L. plantarum Lp91 was the most adhesive strain to the Caco-2 cell lines, with adhesion 
values of approximately 10.2%. They also mentioned that the percentage of adhesion to 
Caco-2 and HT-29 cell lines was higher among the strains isolated from the human faecal 
samples and buffalo milk than that which had been isolated from cheese. 
3. Technological usage of probiotics   
The use of starter cultures in the production of fermented food is necessary for guaranteeing 
safety and standardizing properties.  LAB functions primarily to drop the pH of the batter; 
lower pH a) promotes product safety by inactivating pathogens, b) creates the biochemical 
conditions to attain the final sensory properties through modification of the raw materials, 
and c) improves the product stability and shelf life by inhibiting undesirable changes 
brought about by spoilage microorganisms or abiotic reactions (Ammor & Mayo, 2007).  
Functional starter cultures are defined as microbes that possess at least one inherently 
functional property aimed at improving the quality of the end product (De Vuyst, 2000). The 
use of probiotics in food has reinforced the acclaimed healthy properties and given rise to an 
increased consumption of these products in Europe and the USA (Kristo et al., 2003). 
Probiotics have been evaluated as functional starter cultures in various types of fermented 
food products such as yoghurt, cheese, dry sausage, salami, and sourdough.  They have also 
been studied in therapeutic preparations to assess their positive effects on physico-chemical 
properties of foods and their impact on the nutritional quality and functional performance 
of the raw material (Knorr,  1998; Rodgers, 2008). 
Fermented dairy products are widely-accepted, healthy food products and valued 
components of diets. The incorporation of probiotic bacteria as adjuncts in various 
fermented milk products is currently an important topic with industrial and commercial 
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consequences. A number of dairy products containing probiotic bacteria are currently on the 
market. Fermented milk and cheeses have been described as the most suitable carriers, 
because they enhance the transit tolerance of bacteria (Saarela et al., 2000; Lourens-Hattingh 
& Viljoen, 2001). Some strains of Lactobacillus and Bifidobacterium have been shown to 
tolerate acidic stress when ingested with milk products (Mater et al., 2005). Lactobacilli (e.g. 
L. acidophilus, L. casei subsp. casei, L. gasseri, L. paracasei, L. reuteri and L. rhamnosus) and 
bifidobacteria (e.g. Bifidobacterium adolescentis, B. bifidum, B. breve, B. infantis and B. longum) 
constitute a significant proportion of probiotic lactic acid bacterium cultures used in the 
dairy industry (Wood & Holzapfel, 1995; Klein et al., 1998). It is also important to determine 
the technological features of the strains because they could greatly affect food quality.  
Further, probiotic starter cultures need to be tested for large-scale production feasibility in 
regard to acidification, proteolysis, and aroma formation. They must accomplish this 
without losing viability and functionality or creating unpleasant flavor or texture (De Vuyst, 
2000; Lacroix & Yildirim, 2007). 
Although the number of cells required to produce therapeutic benefits is not known and 
might vary as a function of the strain and the health effect desired, in general a minimum 
level of more than 106 viable probiotic bacteria per mililitre or gram of food product is 
accepted (Ouwehand & Salminen, 1998). The study of new probiotic strains for their 
technological relevance and use in food products is important for trade and industry. The 
search for strains which show resistance to biological barriers of the human GIT, and which 
possess physiological characteristics compatible with probiotic properties among LAB 
isolated from food, may eventually lead to the discovery of new probiotic strains for 
functional food products (Bude-Ugarte et al., 2006). 
Studies of fermented food products as a source of new isolates are rapidly accumulating. For 
example, a mixture of human-derived probiotic strains was tested in the manufacture of ice 
cream; some of the ice cream was sweetened with sucrose and some was sweetened with 
aspartame (Başyiğit et al. 2006). The results showed that neither frozen conditions during 
the storage period nor the type of sweeteners used had any undesired effect on the survival 
of the probiotic cultures. Georgieva et al. (2009) studied technologically relevant properties 
of eight candidate probiotic L. plantarum strains isolated from cheeses. Researchers tested 
their capacity to survive over extended shelf-times at refrigerated temperatures and their 
growth viability in the presence of preservatives widely used in food processing. The 
researchers determined that the cultures’ acidifying and coagulating abilities and enzyme 
activity make them appropriate for diverse food applications, but especially for dairy 
products. In another study, the survival of the probiotic strains L. fermentum (AB5-18 and 
AK4-120) and L. plantarum (AB16-65 and AC18-82), all derived from human faeces, was 
investigated in Turkish Beyaz cheese production (Başyiğit Kılıç et al., 2009). The researchers 
determined the viability of probiotic bacteria in Turkish Beyaz cheese during 4 months of 
ripening and the bacteria’s effect on chemical properties of the cheese. The results of the 
study revealed that the test probiotic culture mix was successful for cheese production and 
did not adversely affect cheese quality during ripening. 
Essid et al. (2009) characterized 17 strains of L. plantarum isolated from traditional Tunisian 
salted meat products to select the most suitable for use as starters for fermenting meat. 
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Critical characteristics included acidification and enzymatic activities responsible for final 
sensory properties; also important were safety characteristics, including antagonistic activity 
against spoilage strains and antibiotic resistance. The researchers determined that all strains 
of L. plantarum had good acidifying activity; however they showed some differences in 
antimicrobial, proteolytic and enzymatic activities. Başyiğit Kılıç et al. (2011b) investigated 
the technological properties of twenty L. plantarum strains to evaluate their potential usage 
as starter cultures in the dairy industry. During two months in cold storage, there were no 
significant changes in the number of bacteria or the pH of the skim milk inoculated with L. 
plantarum strains.    The authors suggested that L. plantarum AC3-10 and AB6-25 can be used 
in industrial yogurt manufacture, based on their technological properties such as proteolitic 
activity, acidifying ability, and production of flavour compounds. 
Floros et al. (2012) tested 19 facultatively heterofermentative lactobacilli from Feta, Kasseri, 
and Graviera cheeses for potential probiotic strains. Data from this study revealed that 
isolates B1, G16, G22, E22, E35, and H30 from Feta; PB2.2 from Kasseri; and 631 from 
Graviera have promising probiotic properties in vitro. β-galactosidase, low proteolytic and 
coagulation activities, and antibacterial activities make them promising candidates as 
adjunct cultures for the food industry. In another study, yoghurt was produced using a 
mixture of potential probiotic L. plantarum AB6-25, AC18-82, AK4-11 and a commercial 
starter culture.  The yoghurt was divided into four experimental batches to which were 
added 0.25%, 0.5%, 1%, and 1.5% β-glucan. The survivability of these potential probiotic 
strains and the physico-chemical properties of the yoghurts were analyzed during a 21-day 
storage period. The highest L. plantarum count was found in the yoghurt containing 0.25% β-
glucan. The study found the best physico-chemical properties to be in the 0.25% and 0.5% β-
glucan containing yoghurts. Therefore, the researchers suggested using 0.25% and 0.5% β-
glucan in yoghurts produced using these potential probiotic bacteria and commercial starter 
culture (Başyiğit Kılıç, 2012). 
Wang et al. (2010) identified and established the functional and technological characteristics of 
potential probiotic Lactobacillus strains isolated from two sources:  the faeces of breast-fed 
infants and traditional Taiwanese pickled cabbages. The authors selected the strains L. reuteri 
F03, L. paracasei F08 and L. plantarum C06 for producing probiotic fermented milk, due to their 
acid and bile tolerance and ability to adhere to Caco-2 cells. The milks were fermented with 
these 3 strains separately, and rats were fed a daily dose of 108 CFU/day for 14 days. After the 
consumption of the Lactobacillus-fermented milk, the rats showed increased faecal lactobacilli 
counts, while the counts of coliform and C. perfringens were significantly decreased. On the 
other hand, Başyiğit Kılıç et al. (2010) investigated the effects of a probiotic culture mix (L. 
fermentum, L. plantarum and E. faecium) and alfa-tocopherol administration on the microbial 
flora in rat GIT and faeces during a 14-day feeding period. The results indicated that the 
probiotic culture and alfa-tocopherol administration had no significant effects on the microbial 
flora of the rat intestinal tract during the 14 days of intake. Minelli et al. (2004) reported that in 
rats administered milk fermented with L. casei, the faecal E. coli counts remained stable, but 
Clostridia counts decreased significantly. Yang et al. (2005) also reported decreased faecal 
coliform counts as one of advantages of Lactobacillus and Bifidobacterium proliferation in the rat 
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gut. Such potentially probiotic bacteria colonizing the intestinal mucosa provide a barrier 
effect against pathogens by using a variety of mechanisms, such as occupation of niches, 
competition for nutrients, and production of antimicrobials (Ouwehand et al., 2001). 
3.1. Methods to increase survival and viability of probiotics 
Researchers have long been encouraged to find new, efficient methods of improving the 
viability of probiotics in food products (especially fermented types), since viability can be 
affected by the acidic-bile conditions of the gastrointestinal tract (Mortazavian et al., 2007). The 
latest developments focus on fermentation technologies for producing probiotic bacteria; new 
approaches for enhancing the performance of these fastidious organisms during fermentation, 
downstream processing, and utilization in commercial products; and improving functionality 
in the gut. Processes to optimize survival and functionality in the gut include sublethal stress 
applications during cell production and new fermentation technologies, such as immobilized 
cell biofilm-type fermentations, are promising in this respect (Lacroix & Yildirim, 2007).  
3.1.1. Immobilized cell biofilm 
Cell immobilization in fermentations is an attractive and rapidly expanding research area 
because of its technical and economic advantages, compared to a free cell system (Stewart & 
Russell, 1986). The immobilization method is cheap, simple and easy (Kourkoutas et al., 
2006). The technology of cell immobilization allows an increase in cell stability and a 
decrease of the lethal effect on the microbial cells, providing protection from the conditions 
of the environment (Champagne et al., 1994; Grosso & Fávaro-Trindade, 2004). Thus 
immobilization techniques could provide protection to acid-sensitive LAB and increase their 
survival rate during the shelf life of the yoghurt and during their passage through the 
gastrointestinal tract (Cui et al., 2000; Fávaro-Trindade & Grosso, 2002). Kushal et al. (2006) 
determined that the process of co-immobilization of probiotic strains of L. acidophilus NCDC 
13 and B. bifidum NCDC 255 resulted in better protection of the viability of the cultures 
during transit through the gastrointestinal tract. In another study conducted by Kourkoutas 
et al. (2006), L. casei cells were immobilized on apple pieces and the immobilized biocatalysts 
were used separately as adjuncts in producing probiotic fermented milk. The results showed 
that the immobilized biocatalyst was able to ferment after storage for 15, 98 and 129 days at 
4 °C, while no infection was reported during storage periods. Denkova et al. (2007) 
determined that the immobilization of the cells of L. acidophilus A., L. helveticus H., L. casei 
subsp. casei C. and L. plantarum 226-15 in chitosan resulted in preparations with high 
concentration of viable cells. The immobilized LAB in the chitosan gel beads was resistant to 
the model conditions of digestion: low and neutral values of pH, enzyme presence, and high 
concentrations of bile salts. 
3.1.2. Encapsulation   
Encapsulation is the process of forming a continuous coating around an inner matrix that is 
wholly contained within the capsule wall as a core of encapsulated material (Kailasapathy, 
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2002). Encapsulation occurs naturally when bacterial cells grow and produce exo-
polysaccharides. The microbial cells are entrapped within their own secretions that act as a 
protective structure or a capsule, reducing the permeability of material through the capsule, 
and making it less exposed to adverse environmental factors. Many LAB synthesise exo-
polysaccharides, but they produce insufficient amounts to encapsulate themselves fully 
(Shah, 2002). Encapsulating probiotics in hydrocolloid beads has been investigated as a 
means of improving their viability and survival in food products and in the intestinal tract 
(Picot & Lacroix, 2004). Other benefits of encapsulation include reduction of cell injury, 
protection of probiotics from bacteriophages (Steenson et al., 1987), increased survival 
during freeze-drying and freezing (Kim & Yoon, 1995), and greater stability during storage 
(Kebary et al., 1998). Several methods of encapsulation have been used on probiotics in 
fermented milk products and biomass production: emulsion or two phase systems, the 
extrusion or droplet method, and spray drying and spray coating (Mortazavian et al., 2007). 
The common materials used for microencapsulation of probiotics are alginate and its 
derivatives, starch, mixtures of xanthan-gelan, carrageenan and its mixtures, gelatin, 
cellulose acetate phethalate, chitosan, and miscellaneous compounds such as whey proteins, 
soybean oil, gums, wax, and calcium chloride (Rao et al., 1989, Picot & Lacroix, 2004, 
Chandramouli et al., 2004). 
Hou et al. (2003) demonstrated that encapsulation of L. delbrueckii spp. bulgaricus 
increased their bile tolerance, and viability was elevated by approximately four log units 
after encapsulation within artificial sesame oil emulsions. Encapsulation in spray dried 
whey protein microcapsules improved survival of B. breve R070 but not that of B. longum 
R023 during refrigerated storage in yoghurt (Picot & Lacroix, 2004). Ding & Shah (2007) 
stated that encapsulation improved the survival of probiotic bacteria including L. 
rhamnosus, B. longum, L. salivarius, L. plantarum, L. acidophilus, L. paracasei, B. lactis type Bl-
O4, and B. lactis type Bi-07 when exposed to acidic conditions, bile salts, and mild heat 
treatment. Capela et al. (2006) found improved viability of probiotic organisms 
encapsulated in 3% v/w sodium alginate in freeze-dried yogurt after 6 months of storage 
at 4 and 21°C. Ozer et al. (2009) studied the viability of encapsulated bacteria in white-
brined cheese;  the researchers used B. bifidum BB-12 and L. acidophilus LA-5 that had been 
encapsulated in Na-alginate by either an extrusion or an emulsion technique. Both 
encapsulation techniques were found to be effective in keeping the numbers of probiotic 
bacteria higher than the level of the therapeutic minimum. While the counts of non-
encapsulated probiotic bacteria decreased approximately by 3 logs, the decrease was more 
limited in the cheeses containing microencapsulated cells (approximately 1 log). Khater et 
al. (2010) tested the ability of twelve non-encapsulated and encapsulated lactic acid and 
bifidobacteria strains to assimilate cholesterol and to survive at a low pH and fairly high 
bile concentrations. The results obtained declared that encapsulation effectively protected 
the microorganisms from the hostile environment in the GIT, thus potentially preventing 
cell loss. The assimilative reductions of cholesterol by non-encapsulated and encapsulated 
strains were clearly different, varying from 32.6% to 89.3% and 27.9% to 85.1% 
respectively. Kim et al. (2008) stated that encapsulation reduces the ability of LAB to 
assimilate cholesterol.  
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4. Effects of probiotics on human health  
Probiotics have the potential for contributing greatly to human and animal health via a wide 
range of applications.  Historically, probiotics have been used in food for humans and 
animals without any side effects, while providing for the balance of intestinal flora 
(Holzapfel & Wood, 1998). The health-promoting effects of probiotics have been widely 
explored and include stabilization of the indigenous microbial population, boosting of the 
immune system, inhibition of the growth of pathogenic organisms, prevention of diarrhea 
from various causes, alleviation of lactose intolerance, increased nutritional value of foods, 
reduction of serum cholesterol levels, antimutagenicity and anticarcinogenicity, reduction of 
the risk of inflammatory bowel conditions, improvement of digestion of proteins and fats, 
synthesis of vitamins, and detoxification  and  protection from toxins (Klaenhammer, 1998; 
Perdigon et al., 2002; Gaudana et al., 2010). 
Anderson & Gilliland (1999) conducted two controlled clinical studies to test effects of 
yoghurt on heart-related health.   They reported an average reduction of serum cholesterol 
by 2.9% with regular consumption of yoghurt containing L. acidophilus and a 6-10% decrease 
in cardiac complications due to hypercholesterolemia. A study by Ouwehand et al. (2002) 
found that a multi-strain probiotic mixture composed of L. reuteri, L. rhamnosus and 
Propionibacterium freudenreichii proved effective in both increasing the number of bowel 
movements and decreasing mucin secretion in elderly subjects. The probiotic mixture was 
more effective than L. reuteri alone, although unfortunately it is difficult to draw conclusions 
about mixtures versus individual probiotics, since only one component of the mixture was 
tested and its dose was over 10 times lower than the total bacterial dose in the mixture. 
Agarwal & Bhasin (2002) have reported that the strain L. casei DN-114001 reduced 
diarrhoeal morbidity by 40% in children.  
Isolauri et al. (1999) found significant improvement when a supplement of either L. 
rhamnosus or B. lactis was given to children from 4 to 6 years of age who had atopic eczema. 
Another study involving pregnant women and newborns suggested that consumption of 
probiotic L. rhamnosus GG reduced the rate of newborns having atopic dermatitis 
(Kalliomaki et al., 2001). In an Australian study, 178 newborns of women with allergies who 
received either L. acidophilus LAVRI-A1 or placebo daily for the first 6 months of life showed 
no difference in atopic dermatitiS. However, at 12 months, the rate of sensitization was 
significantly higher in the probiotic group. These results suggested that the probiotic 
treatment had increased the risk of subsequent cow’s milk sensitization (Taylor et al., 2007).  
Can (2003) used an experimental animal model to study the effects of a probiotic mixture 
and L. GG on immune responses in allergy. The OVA specific IgE levels of the study groups 
which were administred probiotics and reference strain were found lower than the skim 
milk fed groups. A double-blind, randomized, placebo controlled trial study was conducted 
by Abrahamsson et al. (2007) on 188 subjects with allergic disease, in which the mothers 
received L. reuteri ATCC 55730 daily from gestational week 36 until delivery, and their 
babies continued with the probiotic until 12 months. Probiotic supplemented babies showed 
less IgE-associated eczema during the second year. Several probiotic effects are mediated 
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through immuneregulation, particularly through establishing and maintaining a balance 
between pro-and anti-inflammatory cytokines (Isolauri et al., 2001). TNF-a and IL-6 are pro-
inflammatory cytokines, which are produced by the host in response to bacterial 
colonisation or invasion and hence are central to the host defense mechanism against 
pathogens (Solis-Pereyra et al., 1997). Though lipopolysaccharide of Gram-negative bacteria 
is known to stimulate their production, Miettinen et al. (1996) have reported an increase in 
IL-6 and TNF-a production in human PBMC exposed to lactobacilli and thereby suggested 
the use of probiotics as vaccine vectors and for the purpose of stimulating non-specific 
immunity. Kailasapathy & Chin (2000) proved that the synthesis of cytokines is increased as 
the probiotics adhere to the intestinal epithelium.  
Ziarno et al. (2007) studied cholesterol assimilation by commercial starter cultures, reporting 
L. acidophilus monocultures to assimilate cholesterol by 49-55%. In another study involving 
hypercholesterolemic mice, the probiotic potential of L. plantarum PHO4 was established by 
Nguygen et al. (2007). The mice were fed with 107 CFU per day over two weeks. These mice 
had 7 to 10% lesser serum cholesterol and triglycerides than the control mice deprived of the 
probiotic feed. 
Many probiotic species have been identified to be effective in children suffering from 
rotaviral diarrhea (Saavedra, 2000). Longdet et al. (2011) investigated the probiotic efficacy 
of L. casei isolated from human breast milk in the prevention of shigellosis in albino rats 
infected with clinical strains of Shigella dysenteriae. The results showed that the experimental 
rats infected with S. dysenteriae but not treated suffered from shigellosis, while the test 
groups infected and treated with the L. casei showed no sign of the disease as well as no 
clinical effect on the liver.  
Senol et al. (2011a) investigated the protective effect of a probiotic mixture of 13 different 
bacteria and a-tocopherol on 98% ethanol-induced gastric mucosal injury. Levels of gastric 
mucosal pro-and anti-inflammatory cytokines, malondialdehyde, and secretory 
immunglobulin A were measured. Results showed that probiotic pretreatment significantly 
suppressed the ethanol-induced increase of gastric mucosal interleukin-4 levels. 
Pretreatment with either probiotic or a–tocopherol inhibited the ethanol-induced increase of 
mucosal malondialdehyde concentration. Probiotic pretreatment enhanced the gastric 
mucosal secretory immunoglobulin A concentration. The researchers indicated that the 
probitic mixture and a-tocopherol reduced ethanol-induced gastric mucosal lipid 
peroxidation, suggesting that these probiotics may be beneficial for helping heal gastric 
lesions induced by lower ethanol concentration. In another study, the role of a probiotic 
mixture, including 13 different bacteria, in the prevention of aspirin-induced gastric 
mucosal injury was investigated. Pretreatment with the probiotic mixture reduced aspirin-
induced gastric damage and exerted a tendency toward downregulation of 
proinflammatory cytokines elicited by aspirin. Researchers also found that the probiotic 
mixture increased sIgA production approximately 7.5-fold in the stomach, and significantly 
reduced the malondialdehyde increase in the gastric mucosa elicited by aspirin. 
Additionally, pretreatment with the probiotic mixture alleviated aspirin-induced reduction 
 
Lactic Acid Bacteria – R & D for Food, Health and Livestock Purposes 254 
of mast cell count in the gastric mucosa. Probiotic mixture pretreatment attenuates the 
aspirin-induced gastric lesions by reducing the lipid peroxidation, enhancing mucosal sIgA 
production, and stabilizing mucosal mast cell degranulation into the gastric mucosa (Senol 
et al., 2011b). 
5. Final remarks 
Significant data have been accumulated on probiotics and their beneficial health effects. 
Furthermore, more insights and key findings on the impact of processing and storage on 
probiotic viability and stability have been gained. A variety of microorganisms, typically 
food grade LAB, have been evaluated for their probiotic potential and are applied as adjunct 
cultures in various types of food products or in therapeutic preparations. In addition, 
further studies are needed to determine if preventive probiotic strategies are safe with 
regard to development of probiotic infections. Cooperation amongst food technologists, 
medical and nutrition scientists, and anticipation of future consumer demands are crucial 
for future success in probiotics. 
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